MEDINCELL S.A. earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-03-31 | €-0.62 | €-0.62 | 2026-06-19T16:38:26Z |
| 2024 | 2024-03-31 | €-0.88 | €-0.88 | 2026-06-19T16:38:26Z |
Revenue & profit (EUR)
| Concept | 2025 | 2024 |
|---|---|---|
| Revenue | €27.7M | €11.9M |
| Profit for the year | -€18.4M | -€25.0M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in MEDINCELL S.A.'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.